RecruitingNCT06606119

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma


Sponsor

University of Florida

Enrollment

275 participants

Start Date

Jan 24, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Traumatic injury followed by critical illness provokes pathophysiologic changes in the bone marrow and the gut that contribute to persistent anemia and changes in the microbiome which significantly impact long-term recovery. This project will define the interactions between the stress, chronic inflammation, bone marrow dysfunction, and an altered microbiome which will provide a strong foundation for future clinical interventions to help improve outcomes following severe trauma.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria7

  • Severe Trauma Cohort
  • All adults (age ≥18).
  • Blunt trauma with an injury severity score \> 15 and a long bone or pelvic fracture requiring open reduction internal fixation or intramedullary fixation
  • Blunt trauma patients with shock, defined by either a systolic BP (SBP) \<90 mm Hg or base deficit (BD) ≥5 meq or lactate ≥ 2 mmol/L or active red blood cell or whole blood transfusion within 6h or arrival
  • All adults (age ≥55).
  • Patient undergoing elective hip repair for non-infectious reasons.
  • Ability to obtain Informed Consent prior to operation.

Exclusion Criteria17

  • Patients not expected to survive greater than 48 hours
  • Prisoners
  • Pregnancy
  • Previous bone marrow transplantation
  • Patients receiving chronic corticosteroids or immunosuppression therapies
  • Patients with End Stage Renal Disease
  • Patients with any pre-existing hematological disease
  • Surgery for repair of injury is greater than seven days after admission to the hospital for trauma
  • Burn injury greater than 20% TBSA
  • Elective Hip Cohort
  • Patients not expected to survive greater than 48 hours
  • Prisoners
  • Pregnancy
  • Previous bone marrow transplantation
  • Patients receiving chronic corticosteroids or immunosuppression therapies
  • Patients with End Stage Renal Disease
  • Patients with any pre-existing hematological disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData and tissue collection

Collection of bone marrow, blood, feces, medical record data, and patient response surveys.


Locations(3)

UF Academic Research Building

Gainesville, Florida, United States

UF Health at Shands Hospital

Gainesville, Florida, United States

UF Laboratory of Inflammation Biology and Surgical Science and Shands Hospital at UF

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06606119


Related Trials